2014
DOI: 10.1074/jbc.m113.540211
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of Retinoic Acid Biosynthesis by the Bisdichloroacetyldiamine WIN 18,446 Markedly Suppresses Spermatogenesis and Alters Retinoid Metabolism in Mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

5
76
1

Year Published

2015
2015
2021
2021

Publication Types

Select...
7
3

Relationship

3
7

Authors

Journals

citations
Cited by 66 publications
(82 citation statements)
references
References 36 publications
5
76
1
Order By: Relevance
“…Similarly, in normal mice atRA enhances fatty acid oxidation and ketogenesis via RAR activation and FGF21 induction (Amengual et al, 2012;Li et al, 2013). In agreement with a role of atRA in maintaining lipid homeostasis in the liver, decrease of hepatic atRA concentrations via inhibition of atRA synthesis in mice led to microvesicular vacuolation but without a change in liver triglycerides (Paik et al, 2014). However, in diet-induced obese mice atRA treatment decreased hepatic triglyceride content (Berry and Noy, 2009) and hepatic lipid accumulation (Kim et al, 2014).…”
Section: Introductionmentioning
confidence: 57%
“…Similarly, in normal mice atRA enhances fatty acid oxidation and ketogenesis via RAR activation and FGF21 induction (Amengual et al, 2012;Li et al, 2013). In agreement with a role of atRA in maintaining lipid homeostasis in the liver, decrease of hepatic atRA concentrations via inhibition of atRA synthesis in mice led to microvesicular vacuolation but without a change in liver triglycerides (Paik et al, 2014). However, in diet-induced obese mice atRA treatment decreased hepatic triglyceride content (Berry and Noy, 2009) and hepatic lipid accumulation (Kim et al, 2014).…”
Section: Introductionmentioning
confidence: 57%
“…Because of this, further development of WIN 18,446 was abandoned without an understanding of its mechanism of action. Our group demonstrated that WIN 18,446 suppresses spermatogenesis by inhibiting testicular retinoic acid biosynthesis, via inhibition of the testes-specific aldehyde dehydrogenase ALDH1A2 (77, 78). Using a rabbit model, we observed that oral administration of WIN 18,446 induced reversible azoospermia, and reductions in spermatogenesis were preceded by a reduction in intra-testicular retinoic acid.…”
Section: Experimental Male Contraceptivesmentioning
confidence: 99%
“…We recently developed a method using WIN 18,446 and RA to synchronize spermatogenesis in both juvenile and adult testes [22] as a means of overcoming this complexity. WIN 18,446 is a potent inhibitor of the retinaldehyde dehydrogenases (RALDH) [23], the enzymes responsible for oxidizing retinaldehyde to RA, and treatment of male mice with this compound results in a decrease in intratesticular RA levels, blocking male germ cell differentiation and generating testes full of undifferentiated type A spermatogonia [22,23]. Following WIN 18,446 treatment with an injection of RA, spermatogonia begin to differentiate simultaneously, driving synchronous spermatogenesis.…”
Section: Introductionmentioning
confidence: 99%